NO20030820L - Use of vitamin D derivatives as bone resorption inhibitors - Google Patents

Use of vitamin D derivatives as bone resorption inhibitors

Info

Publication number
NO20030820L
NO20030820L NO20030820A NO20030820A NO20030820L NO 20030820 L NO20030820 L NO 20030820L NO 20030820 A NO20030820 A NO 20030820A NO 20030820 A NO20030820 A NO 20030820A NO 20030820 L NO20030820 L NO 20030820L
Authority
NO
Norway
Prior art keywords
vitamin
derivatives
bone resorption
resorption inhibitors
inhibitors
Prior art date
Application number
NO20030820A
Other languages
Norwegian (no)
Other versions
NO20030820D0 (en
Inventor
Seiichi Ishizuka
Kazuya Takenouchi
Imaizumi Atsushi
Yasuhiro Oue
Noriyoshi Kurihara
Sakamuri V Reddy
David G Roodman
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Publication of NO20030820D0 publication Critical patent/NO20030820D0/en
Publication of NO20030820L publication Critical patent/NO20030820L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20030820A 2000-08-23 2003-02-21 Use of vitamin D derivatives as bone resorption inhibitors NO20030820L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000252177A JP2002069003A (en) 2000-08-23 2000-08-23 Deossification inhibitor containing vitamin d derivative
PCT/US2001/022614 WO2002015894A2 (en) 2000-08-23 2001-08-22 Use of vitamin d derivatives as bone resorption inhibitors

Publications (2)

Publication Number Publication Date
NO20030820D0 NO20030820D0 (en) 2003-02-21
NO20030820L true NO20030820L (en) 2003-04-22

Family

ID=18741464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030820A NO20030820L (en) 2000-08-23 2003-02-21 Use of vitamin D derivatives as bone resorption inhibitors

Country Status (7)

Country Link
EP (1) EP1311253A2 (en)
JP (1) JP2002069003A (en)
AU (2) AU8465701A (en)
CA (1) CA2420274A1 (en)
NO (1) NO20030820L (en)
NZ (1) NZ524305A (en)
WO (1) WO2002015894A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003211496A1 (en) * 2002-02-20 2003-09-09 Teijin Limited Vitamin d3 derivatives and remedies using the same
EP1342796A3 (en) * 2002-02-22 2004-01-02 Teijin Limited Compound for the treatment of paget's disease of bone
CA2514614C (en) * 2003-01-30 2011-09-13 Teijin Pharma Limited Vitamin d3 lactone derivatives
US7524980B2 (en) 2003-11-04 2009-04-28 Teijin Pharma Limited Vitamin D3 lactam derivative
EP1683786A4 (en) * 2003-11-04 2008-09-17 Teijin Pharma Ltd Vitamin d3 lactam derivative
JP2007070281A (en) * 2005-09-06 2007-03-22 Matsumoto Shika Univ Remedy for osteoporosis produced by using retinoid x receptor-relating compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2631025B1 (en) * 1988-05-04 1991-04-12 Ire Medgenix Sa NOVEL VITAMIN D3 DERIVATIVES AND APPLICATION TO DETERMINATIONS OF VITAMIN D3 METABOLITES
DE19744127B4 (en) * 1997-10-01 2006-10-05 Schering Ag New vitamin D derivatives with side-chain cyclopropyl rings, processes and intermediates for their preparation and their use in the manufacture of medicaments
US6531460B1 (en) * 1998-10-23 2003-03-11 Teijin Limited Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same

Also Published As

Publication number Publication date
EP1311253A2 (en) 2003-05-21
NO20030820D0 (en) 2003-02-21
AU8465701A (en) 2002-03-04
CA2420274A1 (en) 2002-02-28
NZ524305A (en) 2004-08-27
WO2002015894A3 (en) 2002-08-29
WO2002015894A2 (en) 2002-02-28
AU2001284657B2 (en) 2006-01-19
JP2002069003A (en) 2002-03-08

Similar Documents

Publication Publication Date Title
NO20043158L (en) Substituted quinazoline derivatives as inhibitors of aurorakinases
NO20023828L (en) Pyrimidin-4-one derivatives as LDL-PLA2 inhibitors
NO20030867L (en) Hydroxam derivatives useful as deacetylase inhibitors
NO20033399L (en) Ether derivatives useful as inhibitors of PDE4 isoenzymes
NO20033618D0 (en) Phthalayinone-piperidino derivatives as PDE-4 inhibitors
NO20030055L (en) Colchinol derivatives as angiogenesis inhibitors
NO20014409D0 (en) Dimeric compounds and their use as inhibitors of neuraminidase
DK1244647T3 (en) Quinzoline derivatives as VIGF inhibitors
NO20050665L (en) Pyrrolidone derivatives as MAOE inhibitors
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
EE200300459A (en) Novel spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
NO20041180L (en) Pyrrolopyrimidines as agents for inhibition of cysteine proteases
NO20031450L (en) Fumaric acid derivatives as NF-kappa B inhibitors
DK1556375T3 (en) Flavone derivatives as inhibitors of cyclin-dependent kinases
SE0701538L (en) Azaspiroalkane derivatives as inhibitors of metalloproteases
DE50211250D1 (en) COSMETIC FORMULATION CONTAINING FLAVONOID DERIVATIVES
DK1178986T3 (en) Furanone derivatives as inhibitors of cathepsin S
NO20026262D0 (en) Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
NO20021959D0 (en) Tetrahydrotiopyranephthalazinone derivatives as PDE4 inhibitors
NO20023956L (en) Priperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases
NO20022123D0 (en) Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
PT1322592E (en) SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL
NO20030820D0 (en) Use of vitamin D derivatives as bone resorption inhibitors
NO20043084L (en) 3-Phenyl-2-arylalkylthiopropionic acid derivatives as selective agnoists of PPAR-ALPHA

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application